WallStreetZenWallStreetZen

NASDAQ: NVCR
Novocure Ltd Stock Ownership - Who owns Novocure?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Novocure Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Frank X. LeonardChief Executive Officer2026-06-0434,273$17.93
$614.62kSell
W. Anthony VernonDirector2026-06-022,945$15.77
$46.45kSell
Kristin StaffordDirector2026-06-022,945$15.77
$46.45kSell
Timothy J. ScannellDirector2026-06-022,945$15.77
$46.45kSell
Allyson J. OceanDirector2026-06-022,945$15.77
$46.45kSell
Gabriel LeungDirector2026-06-022,945$15.77
$46.45kSell
David HungDirector2026-06-022,945$15.77
$46.45kSell
Jeryl L. HillemanDirector2026-06-022,945$15.77
$46.45kSell
W. Anthony VernonDirector2026-04-2821,500$11.39
$244.89kBuy
Mukund ParavasthuChief Operating Officer2026-03-0543,246$13.77
$595.67kSell

1 of 5

NVCR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCR insiders and whales buy or sell their stock.

NVCR Shareholders

What type of owners hold Novocure Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
William F. Doyle21.76%25,207,689$448.19MInsider
Fmr LLC14.74%17,069,149$303.49MInstitution
Gert L. Perlhagen12.10%14,018,365$249.25MInsider
Blackrock Inc11.39%13,193,765$234.59MInstitution
Soleus Capital Management LP9.06%10,492,391$186.55MInstitution
Hansjoerg Wyss8.44%9,780,397$173.90MInsider
Volati Ltd6.23%7,216,789$128.31MInsider
Vanguard Portfolio Management LLC5.40%6,251,701$111.16MInstitution
Vanguard Capital Management LLC4.04%4,682,064$83.25MInstitution
Morgan Stanley3.92%4,541,526$80.75MInstitution

1 of 3

NVCR vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCR60.05%39.95%Net SellingNet Selling
AXGN64.21%35.79%Net SellingNet Selling
UFPT87.09%12.91%Net SellingNet Selling
ESTA82.73%17.27%Net SellingNet Selling
TMDX78.02%21.98%Net Buying
View Top Medical Device Stocks

Novocure Stock Ownership FAQ

Who owns Novocure?

Novocure (NASDAQ: NVCR) is owned by 85.38% institutional shareholders, 56.80% Novocure insiders, and 0.00% retail investors. William F. Doyle is the largest individual Novocure shareholder, owning 25.21M shares representing 21.76% of the company. William F. Doyle's Novocure shares are currently valued at $448.19M.

If you're new to stock investing, here's how to buy Novocure stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.